HA JAE CHON: Open Payments
NPI 1649937574 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 54 payments from 15 companies in 2025. Trend: 2023 $784 · 2024 $1,185 · 2025 $1,474
Food & beverage: $1,235Education: $239
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $369 |
| Astellas Pharma US Inc | 5 | $276 |
| United Therapeutics Corporation | 10 | $165 |
| Merck Sharp & Dohme LLC | 7 | $128 |
| Amgen Inc. | 1 | $125 |
| SCPHARMACEUTICALS INC. | 1 | $120 |
| Actelion Pharmaceuticals US, Inc. | 4 | $60 |
| Viatris Specialty LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: NUCALA, TAVNEOS, FUROSCIX, WINREVAIR, Tyvaso, TRELEGY ELLIPTA, UPTRAVI, YUPELRI.
Industry payments across NJ — which companies pay providers there.
